Filing Details

Accession Number:
0001093557-15-000226
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-17 19:00:52
Reporting Period:
2015-07-15
Filing Date:
2015-07-17
Accepted Time:
2015-07-17 19:00:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236388 H Terrance Gregg 6340 Sequence Drive
San Diego CA 92121
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-07-15 15,000 $81.64 417,139 No 4 S Indirect by Trust
Common Stock Disposition 2015-07-17 35,750 $83.67 381,389 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Trust
No 4 S Indirect by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 430,626 Direct
Common Stock 11,461 Indirect by IRA
Footnotes
  1. On December 12, 2014, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  2. This transaction was executed in multiple trades at prices ranging from $81.32 to $82.34. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.
  4. The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated March 5, 2015 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $83.67 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the July 17, 2015 closing of the exchange fund.